Cargando…
Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrar...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214327/ https://www.ncbi.nlm.nih.gov/pubmed/35755292 http://dx.doi.org/10.1016/j.apsb.2021.10.009 |
_version_ | 1784730990206255104 |
---|---|
author | Liu, Ying Han, Yu Chen, Shizhu Liu, Jingjie Wang, Dajiang Huang, Yifei |
author_facet | Liu, Ying Han, Yu Chen, Shizhu Liu, Jingjie Wang, Dajiang Huang, Yifei |
author_sort | Liu, Ying |
collection | PubMed |
description | Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma. |
format | Online Article Text |
id | pubmed-9214327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92143272022-06-23 Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma Liu, Ying Han, Yu Chen, Shizhu Liu, Jingjie Wang, Dajiang Huang, Yifei Acta Pharm Sin B Original Article Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma. Elsevier 2022-06 2021-10-22 /pmc/articles/PMC9214327/ /pubmed/35755292 http://dx.doi.org/10.1016/j.apsb.2021.10.009 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Liu, Ying Han, Yu Chen, Shizhu Liu, Jingjie Wang, Dajiang Huang, Yifei Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title | Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title_full | Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title_fullStr | Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title_full_unstemmed | Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title_short | Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
title_sort | liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214327/ https://www.ncbi.nlm.nih.gov/pubmed/35755292 http://dx.doi.org/10.1016/j.apsb.2021.10.009 |
work_keys_str_mv | AT liuying liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma AT hanyu liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma AT chenshizhu liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma AT liujingjie liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma AT wangdajiang liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma AT huangyifei liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma |